Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intense Pulsed Light (IPL) and Meibomian Gland Expression to Treat Ocular Rosacea Secondary to Inactive Chronic Ocular Graft Versus Host Disease (GVHD)

NCT02066051 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02066051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02066051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intense Pulsed Light (IPL) and Meibomian Gland Expression to Treat Ocular Rosacea Secondary to Inactive Chronic Ocular Graft Versus Host Disease (GVHD)
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2013
Completion date
November 30, 2014
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndrome, gvhd, ocular rosacea